1. Home
  2. LYB vs DGX Comparison

LYB vs DGX Comparison

Compare LYB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LyondellBasell Industries NV (Netherlands)

LYB

LyondellBasell Industries NV (Netherlands)

HOLD

Current Price

$74.10

Market Cap

25.9B

Sector

Industrials

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$198.64

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYB
DGX
Founded
1955
1967
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.9B
23.1B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
LYB
DGX
Price
$74.10
$198.64
Analyst Decision
Hold
Buy
Analyst Count
16
13
Target Price
$68.00
$208.62
AVG Volume (30 Days)
7.8M
621.3K
Earning Date
05-01-2026
04-21-2026
Dividend Yield
3.44%
1.75%
EPS Growth
N/A
13.78
EPS
N/A
8.75
Revenue
$30,153,000,000.00
$11,035,000,000.00
Revenue This Year
$1.93
$7.53
Revenue Next Year
$0.13
$3.77
P/E Ratio
N/A
$22.47
Revenue Growth
N/A
11.78
52 Week Low
$41.58
$159.83
52 Week High
$83.94
$213.50

Technical Indicators

Market Signals
Indicator
LYB
DGX
Relative Strength Index (RSI) 52.53 51.11
Support Level $44.50 $194.09
Resistance Level $83.94 $203.96
Average True Range (ATR) 3.73 4.22
MACD -0.70 0.10
Stochastic Oscillator 36.23 58.05

Price Performance

Historical Comparison
LYB
DGX

About LYB LyondellBasell Industries NV (Netherlands)

LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: